{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477318627
| IUPAC_name =  
| image = Alovudine.svg
| width = 200
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 25526-93-6
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 33039
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 30578
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = PG53R0DWDQ
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02830
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 105318
| synonyms =
<!--Chemical data-->
| C=10 | H=13
| F=2 | N=2
| O=4
| molecular_weight = 244.22 g/mol
| smiles = O=C/1NC(=O)N(\C=C\1C)[C@@H]2O[C@@H]([C@@H](F)C2)CO
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UXCAQJAQSWSNPQ-XLPZGREQSA-N
}}
'''Alovudine''' was an [[antiviral drug|antiviral]] agent being developed by Medivir, which was discontinued after a Phase II trial in 2005 due to toxicity.  It was a [[DNA polymerase]] inhibitor.<ref>Georgopapadakou N. Discontinued drugs in 2005: anti-infectives. Expert Opin Investig Drugs. 2007 Jan;16(1):1-10. {{PMID|17155849}}</ref>

==References==
{{Reflist}}
{{HIVpharm}}
{{DNA antivirals}}
{{RNA antivirals}}

[[Category:Antivirals|Antivirals]]
[[Category:Pyrimidinediones]]
[[Category:Organofluorides]]
[[Category:Abandoned drugs]]


{{antiinfective-drug-stub}}